<page><tag>4</tag><title>MedImmune Forms Research Partnership</title><text>MedImmune Inc. will pay a New Jersey biotech company \$15 million to collaborate with it on potential new treatments for autoimmune diseases, starting with lupus. &amp;lt;FONT face="verdana,MS Sans Serif,arial,helvetica" size="-2" color="#666666"&amp;gt;&amp;lt;B&amp;gt;- The Washington Post&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;</text></page>